Results for “”

Entry Author Date Location
FDA Lifts Solid Bio Clinical Hold, Duchenne Study Cleared to Resume 10/01/20 Boston
Genfit Restructuring Cuts Staff by 40%, Creates Two New Subsidiaries 09/30/20 Europe
Pfizer Pumps $200M Into CStone for Rights to PD-L1 Cancer Drug in China 09/30/20 New York
With Phase 2 Data in Hand, Ovid Eyes Multiple Pivotal Trials for Epilepsy Drug 09/30/20 New York
Orphazyme Stock Sale Reaps $83M as Neimann-Pick Drug Review Begins 09/29/20 Europe
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs 09/28/20 Boston
Galecto Picks Up $64M as Plans for Fibrosis Clinical Trials Move Forward 09/25/20 Europe
Bio Roundup: Grail Acquisition, Libra’s Launch, Tau Trial Results & More 09/25/20 National
Combined Therapeutics Inc Wins $250,000 MilliporeSigma Advance Biotech Grant 09/25/20 National
Monte Rosa Raises $96M for “Glue-Based” Protein Degrading Drugs 09/24/20 Boston
And the 2020 National Xconomy Awards Winners Are… 09/24/20 National
Libra Strikes a Balance With Approach to ALS and Other Neuro Disorders 09/23/20 San Diego
Tau-Targeting Alzheimer’s Drug from AC Immune, Roche Fails in Phase 2 09/23/20 Europe
Athira CEO Kawas: Alzheimer’s Drug Aims for “Recovery of Brain Function” 09/23/20 Seattle
Gene Therapy Firms Seek Clarity on FDA Exclusivity, Orphan Designations 09/22/20 National
Xconomy Awards On-Demand ‘Meet the Finalists’ Webcast Series Continues This Week 09/21/20 Boston
Illumina to Acquire Cancer Diagnostics Developer Grail in $8B Deal 09/21/20 San Francisco
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More 09/18/20 National
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D 09/17/20 Boston
BIO Chief: “Reckless” Executive Order on Drug Prices Threatens Innovation 09/17/20 Boston
Finch Therapeutics Fetches $90M to Advance Microbiome Drug Pipeline 09/17/20 Boston
Arrowhead Pharma Shares Soar on Early Liver Data for RNAi Drug 09/16/20 Wisconsin
Moderna CMO Talks COVID-19 Vaccine at the Xcelerate Keynote Series 09/16/20 Boston
Neogene Therapeutics Grabs $110M to Tackle Solid Tumors With Cell Therapy 09/15/20 Europe
Unity Bio Restructuring Cuts 30% of Staff, Keeps Focus on Eye Drug 09/15/20 San Francisco
Seattle Genetics Lands $1.72B From Merck in Pair of Cancer Drug Deals 09/14/20 Seattle
Gilead Adds “Cornerstone” Cancer Drug in $21B Immunomedics Buyout 09/14/20 San Francisco
Join Xconomy Next Week at the Virtual Xcelerate Keynote Series at Biotech Week Boston 09/14/20 Boston
Bio Roundup: COVID-19 Pact, Gavreto Approval, Generative Biology & More 09/11/20 National
Now Closer to Clinical Trials, Codiak BioSciences Refiles IPO Plans 09/10/20 Boston
Page 1 of 1973 next page »